Why is Titan Biotech Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
With a growth in Net Profit of 107.11%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 2 consecutive quarters
- PBT LESS OI(Q) Highest at Rs 9.30 cr.
- NET SALES(Q) Highest at Rs 56.51 cr
- PBDIT(Q) Highest at Rs 10.84 cr.
3
Market Beating performance in long term as well as near term
- Along with generating 342.39% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you buy?
- Overall Portfolio exposure to Titan Biotech should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Titan Biotech for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Titan Biotech
342.39%
5.39
63.50%
Sensex
-3.52%
-0.27
12.93%
Quality key factors
Factor
Value
Sales Growth (5y)
8.72%
EBIT Growth (5y)
-6.32%
EBIT to Interest (avg)
26.27
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
1.22
Tax Ratio
25.09%
Dividend Payout Ratio
6.65%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
25.43%
ROE (avg)
21.23%
Valuation Key Factors 
Factor
Value
P/E Ratio
61
Industry P/E
37
Price to Book Value
9.94
EV to EBIT
57.19
EV to EBITDA
49.56
EV to Capital Employed
9.66
EV to Sales
8.61
PEG Ratio
2.90
Dividend Yield
0.10%
ROCE (Latest)
13.46%
ROE (Latest)
13.86%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
Technical Movement
28What is working for the Company
PBT LESS OI(Q)
Highest at Rs 9.30 cr.
NET SALES(Q)
Highest at Rs 56.51 cr
PBDIT(Q)
Highest at Rs 10.84 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 19.18%
PAT(Q)
Highest at Rs 8.53 cr.
EPS(Q)
Highest at Rs 10.33
-3What is not working for the Company
ROCE(HY)
Lowest at 16.04%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.88 times
Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 9.30 cr has Grown at 164.96%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 8.53 cr has Grown at 94.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 56.51 cr has Grown at 47.62%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 9.30 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 56.51 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 10.84 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 19.18%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit After Tax (PAT) - Quarterly
Highest at Rs 8.53 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 10.33
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Titan Biotech
Debtors Turnover Ratio- Half Yearly
Lowest at 5.88 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio






